Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis

 

Not intended for U.S media

  • Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS 
  • #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those impacted by MS

DARMSTADT, Germany, Oct. 11, 2018 /CNW/ - Merck, a leading science and technology company, today announced the publication of results from a global Merck-sponsored multiple sclerosis (MS) carer survey, as well as the premiere of the #MSInsideOut documentary film, Seeing MS from the Inside Out, executive produced by Shift.ms, a social network for people with multiple sclerosis, at the 34th Congress of the European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS), in Berlin, Germany.

To view the Multimedia News Release, please click:
https://www.multivu.com/players/uk/8411851-merck-survey-and-film-multiple-sclerosis/

The 'Living with Multiple Sclerosis: The Carer's Perspective report was developed in collaboration with The International Alliance of Carer Organizations (IACO) and Eurocarers to examine the experiences of 1,050 multiple sclerosis (MS) carers across seven countries (US, Canada, UK, France, Germany, Italy and Spain). The survey found that almost half (48%) of those surveyed became MS carers when they were below the age of 35, and nearly one in three had been caring for somebody for 11 years or more.

Additional key findings from the carer survey included:

  • 43% and 28% of carers surveyed reported an impact on their emotional/mental health and physical health respectively
  • 34% said being an MS carer impacted their financial situation, more than a third (36%) stated they had to take time off work, and as a result, 84% of those carers reported their work and career being impacted
  • Only 15% of carers surveyed connected with other carers or patient organisations to help cope with the challenges of their role

"MS can be a devastating disease for both patients and carers, with the responsibilities assumed by carers over an extended length of time and intensifying as the disease progresses. Carers can experience a profound impact on their physical and emotional health, finances, and employment," said Nadine Henningsen, Board Chair, IACO. "Not surprisingly, the survey results reinforced the large number of young people who are becoming carers - often in a formative time of their life."

As part of the #MSInsideOut campaign, an initiative aimed at providing a deeper understanding of MS, the MS Inside Out documentary film, 'Seeing MS from the Inside Out', will be premiered. Developed with Shift.ms as executive producers, it is the first global documentary film to pair artists and people from across the MS community, with a view to interpreting the experiences and perspectives of those impacted by MS through art.

"In line with our broader mission at Shift.ms, the aim of this documentary is to highlight the individual stories in a unique and innovative way across the MS community, digging deeper into the elements of MS that remain under-represented with a view of interpreting the unmet needs of those impacted by MS through art," said George Pepper, Co-founder and CEO, Shift.ms. "By bringing these stories out into the open we will be able to address those challenges that remain, opening lines of communication and ultimately raising awareness of MS."

The documentary follows three stories: Maria Florencia, a person living with MS from Argentina, Jon Strum, a caregiver from the US, and Dr. Luigi Lavorgna, a healthcare professional from Italy. Each was paired with a local visual artist to bring their stories to life through an emotional interpretation not bound by words but through art, reflecting the often difficult-to-explain nature of MS.

The premiere will take place at 18.00 - 19.30 CEST today on October 11, during ECTRIMS 2018 and can be accessed through a livestream link here: http://www.touch-stream.com/MSinsideout

"At Merck, we are extremely proud to highlight the unmet needs in the community through our work with Shift.ms, IACO and Eurocarers which expose the experiences of different members of the MS community, including the perspective of MS carers, whose voices have traditionally not been heard as strongly," said Andrew Paterson, Senior Vice President, Global Head of Neurology and Immunology, at the biopharma business of Merck. "Forming part of our ongoing company-wide commitment to carers, and connecting with the broader Embracing Carers initiative, the outcomes from both the survey and documentary film highlight the need for additional support and awareness. We therefore encourage and call upon the MS community to take these findings and identify ways in which they can better assist both MS carers and patients."

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

About Multiple Sclerosis

Multiple sclerosis (MS) is a chronic, inflammatory condition of the central nervous system and is the most common, non-traumatic, disabling neurological disease in young adults. It is estimated that approximately 2.3 million people have MS worldwide. While symptoms can vary, the most common symptoms of MS include blurred vision, numbness or tingling in the limbs and problems with strength and coordination. The relapsing forms of MS are the most common.

Merck in Multiple Sclerosis

Merck has a long-standing legacy in neurology and immunology, with significant R&D and commercial experience in multiple sclerosis (MS). Merck's current portfolio includes two products for the treatment of relapsing MS, with a robust pipeline focusing on discovering new therapies that have the potential to modulate key pathogenic mechanisms in MS. Merck aims to improve the lives of those living with MS, by addressing areas of unmet needs.

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. More than 53,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

About Embracing Carers

Embracing Carers is a global initiative led by Merck KGaA in collaboration with leading caregiver organizations around the world designed to increase awareness, discussion, and action about the often-overlooked needs of caregivers. Given that caregivers need support and often do not know where to turn for help, Embracing Carers was created to help fill that void.

About IACO

The International Alliance of Carer Organizations (IACO) is a global coalition of 15 member nations committed to building a global understanding and respect for the vital role of family carers. Recognized as an official NGO by the United Nations, IACO works to improve the quality of life and support the needs of carers, through international partnerships and advocacy that strengthens and honors the voice of carers. To learn more, visit http://www.internationalcarers.org.

About Eurocarers

Eurocarers is the European umbrella organisation representing informal carers and their organizations, irrespective of the particular age or health need of the person they are caring for. Eurocarers works to raise awareness of the significant contribution made by carers to care systems while ensuring that all relevant policies across Europe take account of their needs and preferences. To learn more, visit http://www.eurocarers.org.

About Shift.ms

Shift.ms - http://www.Shift.ms - is the social network for people with multiple sclerosis. Founded by MSers, for MSers, the charity supports many thousands of recently diagnosed people across the world as they make sense of MS. It's independent and it's free.

About #MSInsideOut

#MSInsideOut is a campaign supported by Merck which focuses on understanding the journeys people living with MS face and telling the inside story of the disease. For more than 20 years, Merck has been relentlessly focused on understanding the journey people living with MS face to create a meaningful, positive experience for them and the broader MS Community. With the #MSInsideOut campaign Merck aims to better understand MS and, importantly, enable others to do the same.

(Logo: https://mma.prnewswire.com/media/697963/Merck_MS_Inside_Out_Logo.jpg)

Video: https://www.multivu.com/players/uk/8411851-merck-survey-and-film-multiple-sclerosis/

SOURCE Merck

West Park Healthcare Centre unveils plans for new $1.2B Toronto hospital

 

TORONTO, Oct. 11, 2018 /CNW/ - West Park Healthcare Centre broke ground today on a massive new construction project that will redefine how nature can effectively be integrated into rehabilitative health care.

The project, with a contract value of $1.2 billion, will include construction of a new six-storey hospital overlooking the Humber River valley. The new hospital, scheduled to open in 2023, will feature 80 per cent of the beds being in single-patient rooms, with each inpatient having a private three-piece washroom for improved infection control. There will also be a significant increase in outpatient care space to serve double the current patient volume.

"The work that happens at the West Park Healthcare Centre is incredible," said Premier Doug Ford.  "For more than a century they've made a huge difference for countless patients and their families.  Our government is proud to support West Park and its healthcare staff."

"This is a very proud moment after a decade of careful planning and extensive consultation, including valuable input from our patients," said Anne-Marie Malek, West Park's President and CEO. "We can now envision welcoming patients in our new, world-class hospital facility and helping them get their lives back."

The West Park development will amplify the role of the 27-acre campus' natural surroundings through terraces on every floor, many outdoor therapeutic spaces as well as numerous trails and gardens. Research shows that connecting and engaging with nature supports the psychological and emotional well-being of patients and their families.

"The redevelopment represents our opportunity to create a new integrated campus of care where nature and healing intersect – inside and out," said Malek.

"The new West Park Healthcare Centre is an important project that will support patients and families in Toronto by providing access to therapeutic spaces for generations to come," said Christine Elliott, Minister of Health and Long-Term Care. "This unique hospital will offer specialized rehabilitative and complex care while focusing on bringing peace of mind to patients rehabilitating from a life-altering illness or injury. I look forward to the opening of this new building in the beautiful Humber River Valley."

West Park Foundation has launched the $80 million Get Your Life Back Campaign – the largest fundraising endeavour in the history of West Park – to support the capital costs of the new hospital. Phase 1 of the Campaign will raise $50 million by 2023, with the Foundation providing an additional $30 million dollars in support to the new hospital over the next 30 years.

To date, more than $21 million has been raised, representing 42 per cent of the Phase 1 goal.

"We are proud to partner in West Park's bold transformation. The Campaign will ensure that the new hospital is a leading-edge facility, and a match for the courage of our patients and the commitment of our staff," says Joanne Cole, CEO of West Park Foundation.

"Our government is committed to making life easier for families, seniors, businesses and students," said Monte McNaughton, Minister of Infrastructure. "That means making smart investments in reliable infrastructure like the new West Park Healthcare Centre, a facility that will improve care for people in our community."

"We are extremely proud to celebrate today's groundbreaking with all of our public and private partners," said Ehren Cory, President and CEO, Infrastructure Ontario. "Our approach to delivering large, important public sector projects like West Park also delivers value for money on government priorities such as health care."

EllisDon Infrastructure Healthcare (EllisDon) has been awarded the fixed-price contract to design, build, finance and maintain the new hospital. The contract is valued at $1.2 billion, which reflects the payments made during construction, the substantial completion payment, and the facility maintenance payments over 30 years.

About West Park Healthcare Centre:
West Park Healthcare Centre helps patients get their lives back by providing specialized rehabilitative and complex care after a life‐altering illness or injury such as lung disease, amputation, stroke, and traumatic musculoskeletal injuries. West Park is building a new hospital and transforming its 27-acre site into an integrated campus of care, enabling the hospital to evolve its rehabilitative programs to meet Ontario's future healthcare needs.

SOURCE West Park Healthcare Centre

Siemens Healthineers Announces the Expansion of Ottawa Manufacturing Facility

 

  • Manufacturing facility in Ottawa, Ontario, to be expanded to support increased manufacturing of point-of-care analyzer

OAKVILLE, ON, Oct. 11, 2018 /CNW/ - Siemens Healthineers has announced that its Ottawa, Ontario manufacturing facility that manufactures the epoc® blood analysis system will be expanded by 5000 square feet to support new manufacturing lines and accommodate growth of the healthcare business worldwide and in Canada.

The epoc system is a handheld, wireless solution that enables comprehensive blood analysis testing at the patient's side on a single room-temperature test card, with results in less than a minute.

"This investment is a critical step toward enabling the growth of our medical technology business in Canada and Ontario by ensuring we have the manufacturing capacity in place to support continued development," said Eric LaFleche, General Manager of Siemens Healthineers in Canada. "We are proud that the skills and experience of staff are recognized, and Canada continues to be known for its technology, skills, and favourable innovative business environment."

The 5000 square-foot expansion is expected to be complete by June 2021, and will complement the company's other point-of-care operations in the United States, United Kingdom, and India.

The point-of-care testing portfolio from Siemens Healthineers includes several solutions designed to provide immediate, convenient, and easy-to-use diagnostic testing. From the emergency department to the physician's office, clinical management decisions can be made immediately and result in improved patient safety, clinical outcomes, and overall patient satisfaction. The Ottawa facility is focused on the manufacture of the epoc blood analysis system, which provides critical caregivers with real-time, laboratory quality test results at the patient's bedside.

The epoc blood analysis system can be used for a wide range of tests including: blood gas, which measures the amount of oxygen and carbon dioxide in the blood that can indicate the presence of certain medical conditions such as kidney disease, heart failure, diabetes, hemorrhage, chemical poisoning, a drug overdose, or shock, among others; electrolytes and metabolytes, which indicate kidney health, blood sugar levels, and levels of electrolytes such as potassium and sodium; lactate that tests for sepsis; creatinine, which indicates kidney function; and blood urea nitrogen that reveals information about how well the kidneys and liver are functioning.

More information on the Siemens Healthineers epoc blood analysis system is available online.

Follow us on Twitter at: https://twitter.com/SiemensHealth

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.7 billion and adjusted profit of €2.5 billion and has about 48,000 employees worldwide. Further information is available at www.siemens-healthineers.com.

SOURCE Siemens Healthineers

Harris Williams Advises SlimFast on its Pending Sale to Glanbia plc

 

Richmond, Virginia, October 11, 2018 – Harris Williams, a preeminent middle market investment bank focused on the advisory needs of clients worldwide for more than 25 years, announces the pending sale of SlimFast, a portfolio company of Kainos Capital, LLC (Kainos), to Glanbia plc (Glanbia). SlimFast is a leading brand of weight management and meal replacement products. The transaction is being led by Tim Alexander, Ryan Freeman, Andy Warczak, and David Stead of Harris Williams’ Consumer Group.

 

“SlimFast is one of the most recognizable weight management brands in North America and the U.K.,” said Tim Alexander, a managing director at Harris Williams. “With its 40-year history and strong momentum driven by its recent introductions of SlimFast Advanced Nutrition, SlimFast Advanced Energy and SlimFast Keto, the company is one of the fastest growing weight management brands today.”

 

“SlimFast’s addition to the Glanbia Performance Nutrition global brand portfolio will provide SlimFast with unique opportunities to accelerate growth through continued innovation and increased distribution into new geographies,” said Ryan Freeman, a director at Harris Williams. “We are proud to have represented SlimFast and are excited to follow the company’s future success.”

 

SlimFast, founded in 1977 and based in Palm Beach Gardens, Florida, offers a clinically-proven plan with delicious meal replacement protein shakes, smoothie mixes, bars, cookies, supplements, 100-calorie snacks and coffee beverages. SlimFast has clinical trials demonstrating proven weight loss. Products can be purchased at mass, grocery and online retailers, in the U.S., Canada, Mexico, U.K. and China.

 

Kainos is a middle market private equity firm with an exclusive focus on the food and consumer sector. The Kainos team has extensive investment and operating experience in the industry, having invested more than $2 billion of equity in more than 60 transactions with a total transaction value of more than $10 billion. The firm's strategy is to build a diversified portfolio of growing and strategically relevant food and consumer businesses that trade buyers would like to acquire.

 

Glanbia is a global nutrition company, grounded in nature and science dedicated to providing better nutrition for every step of life’s journey. Glanbia has deep roots in the dairy industry and has become a leading producer and marketer of quality performance nutrition products supporting active lifestyles. Its success as a global ingredients provider has been built on Glanbia’s expertise in nutritional solutions supported by significant investment in research and development. With total group revenues of €3.6 billion in 2017, 6,600 employees and a presence in 32 countries worldwide, Glanbia’s vision is to be one of the world’s top performing nutrition companies, trusted to enrich lives every day.

 

Harris Williams (www.harriswilliams.com), a subsidiary of the PNC Financial Services Group, Inc. (NYSE:PNC), is a preeminent middle market investment bank focused on the advisory needs of clients worldwide.  The firm has deep industry knowledge, global transaction expertise and an unwavering commitment to excellence. Harris Williams provides sell-side and acquisition advisory, restructuring advisory, board advisory, private placements and capital markets advisory services.

 

Harris Williams’ Consumer Group has completed more than 50 transactions in recent years across a variety of verticals, including branded consumer products; consumer services; food, beverage and agribusiness; and restaurant and retail.  For more information on Harris Williams’ Consumer Group and other recent transactions, visit the Consumer Group’s section of the Harris Williams website.

 

Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is a private limited company incorporated under English law with its registered office at 5th Floor, 6 St. Andrew Street, London EC4A 3AE, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams is a trade name under which Harris Williams LLC and Harris Williams & Co. Ltd conduct business.

Green Relief Inc. The Leading Licensed Producer in Canada to use Aquaponics Technology to Grow Cannabis

-Donating fish used in their aquaponic systems to shelters across the GTA-

HAMILTON, ON, October 11, 2018 - Green Relief Inc., a licensed producer of medical cannabis in Flamborough, Ontario, has become the world’s leading expert on growing cannabis on a commercial scale using aquaponics. Aquaponics is a sustainable form of agriculture where fish and plants are grown together in a natural ecosystem-based environment. Aquaponics combines the best attributes of aquaculture and hydroponics without the use of chemical additives or having to discard harmful water into the environment. It can produce more than ten times the crop yield per acre and uses 90% less water than conventional farming.
With the natural resources of our planet being depleted at an alarming rate, Green Relief believes in striving to embed sustainability in every fiber of its company through awareness, involvement, and innovation. They incorporate strong environmental, health, and social values in everything they do from the geothermal advantage of their earth-sheltered building to the 100% use of energy-saving LED lights and environmentally responsible aquaponic growing systems. From their planned integration of job positions for the physically disabled through the Ontario Disability Employment Network to donating organically fed tilapia to the local homeless shelters for people in need.

Green Relief’s team of exceptional horticulturalists, scientists, and aquaponic specialists are committed to and actively engaged in the company’s mandate for sustainability. It’s this greater purpose that has created such a powerful company culture where all the employees are personally engaged in a process where they can actually see how they are improving peoples’ lives and making a difference in the world. Exceptional people growing an exceptional plant.

At Green Relief, the cannabis plants are propagated from carefully selected mother plants that are replaced regularly to ensure that the strong genetics of each strain is maintained for optimum cannabinoid and terpene production. This ensures that medical cannabis is consistent from batch to batch resulting in a dependable and high-quality product. Carefully tracked batches of each plant strain are harvested every two weeks to ensure maximum freshness, quality, and traceability is maintained for their patients.

The highly qualified Quality Assurance team at Green Relief ensures that all procedures and protocols are strictly applied during the growing, harvesting, drying, and extracting processes for their medical cannabis. All their products undergo strict testing by both their in-house scientists and third-party laboratories. Products are tested for potency levels as well as for microbiological contaminants, heavy metals, pesticides, and aflatoxins to ensure that patients are receiving a safe and consistent product in every order.

Warren Bravo is the co-founder and CEO of Green Relief Inc., a licensed producer devoted to bringing innovation and social responsibility to the medical cannabis industry through the use of aquaponics. In the early 1980’s, Warren became the third-generation of the Bravo family to join the family business, Bravo Cement Contracting. By the early 1990’s, Warren had climbed the ladder to company president, leading the firm to become one of the most significant concrete companies in Canada with a worldwide presence. In 2013, Warren took a leap of faith leaving Bravo Cement to establish Green Relief Inc. with co-founder Steve LeBlanc. Their mission: help patients improve their quality of life while furthering the science of medical cannabis and sustainable agriculture around the world.

Recently, Green Relief has expanded its operations by acquiring a 100,000 sq.ft. Facility in nearby Stoney Creek, Ontario, providing a real boost to the local economy. The facility, which will contain 75,000 sq. ft. of growing area and 25,000 sq. ft. of office space, allows Green Relief to grow its medicinal products on a much larger scale. The building will act as an extension of the company’s headquarters in Flamborough and includes plans for installing a second floor, which will double the production output. Green Relief will be hosting a job fair in the coming months and is very excited to be expanding employment opportunities in the Stoney Creek area by creating approximately 100 new living wage jobs. Green Relief also plans to go public giving an initial public offering (IPO) in the coming months.

-30-

About Green Relief Inc. Green Relief Inc. is a licensed Canadian producer of medical cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and are fully licensed to produce and sell both dry cannabis products and cannabis oils. Their mission: To help patients improve their quality of life, invest in furthering the science of medical cannabis through meaningful research, and advance sustainable agriculture around the world through aquaponics.

www.greenrelief.ca

Hey guys!

I have some amazing news! If you haven’t heard yet...my sponsor Pharmafreak now has online ordering on their new website!

This includes all products and apparel! Use my code and save on your order: Trainitright10 ??????

Just visit www.pharmafreak.com and use Trainitright10 at check out!

Ontario Expands Hospital Donation Performance Reporting

 

TORONTO, Oct. 11, 2018 /CNW/ - Trillium Gift of Life Network, the government agency responsible for organ and tissue donation and transplant, has developed a new metric to measure Ontario hospitals' performance in organ donation: the eligible approach rate.

A hospital's eligible approach rate measures the number of families approached to discuss the potential of organ donation for their loved one against the total number of cases where donation was a possibility, and a family could have been approached. This new hospital donation performance metric was developed to increase opportunities for Trillium Gift of Life Network to approach families about donation.

"Trillium Gift of Life Network is dedicated to ensuring that when donation is an option, families have the opportunity to consider giving the gift of life," said Ronnie Gavsie, President and CEO, Trillium Gift of Life Network. "Families often tell us that donation brought them comfort in their grief. We must ensure that the choice to save lives is made available to all families of potential donors."

Ontario is the only province to publicly report on hospital performance in organ and tissue donation. This practice has contributed to higher donation rates, making Ontario the leader in Canada.

From April 1 – June 30, 2018, 55 Ontario hospital corporations collectively achieved an eligible approach rate of 82 per cent. A hospital's eligible approach rate is affected by a variety of factors, including the extent to which hospitals have donation policies to facilitate timely referrals to Trillium Gift of Life Network.

Since 2013, Trillium Gift of Life Network has reported on two other performance indicators: routine notification rate and conversion rate.

Routine notification rate measures the frequency at which hospitals notify Trillium Gift of Life Network of a patient death or imminent death. Without this critical first step, precious life-saving opportunities are lost. From April 1 – June 30, 2018, 69 designated hospital corporations in Ontario collectively achieved a 96 per cent routine notification rate.

Conversion rate measures the percentage of potential organ donors that became actual organ donors. During the same reporting period, 55 designated hospitals corporations together achieved an average of 60 per cent conversion rate.

Quick facts

  • Only two to three per cent of hospital deaths occur in circumstances that permit organ donation.
  • Donation performance data including eligible approach rate, routine notification rate and conversation rate, by hospital, is available at www.giftoflife.on.ca/en/publicreporting.htm.
  • One donor can save up to eight lives and enhance up to 75 more through tissue donation.
  • Register or learn more about donation at www.BeADonor.ca.

Trillium Gift of Life Network is the Government of Ontario agency responsible for planning, promoting, coordinating and supporting organ and tissue donation and transplantation across the province and for continually improving the system so that more lives can be saved.

SOURCE Trillium Gift of Life Network

Healthy Lifestyle Habits Can Prevent Dementia

Chattanooga, TN, October 10, 2018 ― Dr. Timothy R. Jennings speaks expertly on a subject that concerns over 5.5 million people across the nation: how to prevent dementia and keep our mind sharp as we age. A psychiatrist and international speaker, Jennings introduces his new book, recently rated #1 by Amazon in books on dementia, The Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind.

Dr. Jennings prescribes simple, everyday actions we can take to stave off disease, promote vitality, and prevent dementia and late-onset Alzheimer's. "The choices we make now can help us to keep our minds sharp and maintain our independence as we age,” says Jennings.

An easy-to-use guide to maintaining brain and body health throughout life, The Aging Brain is based on solid, up-to-date scientific research, and the interventions discussed can prevent progression toward dementia, even in those already showing signs of mild cognitive impairment. The recommendations also may help reduce disability and depression.

"This book isn't just for people hoping to slow the aging process,” says Jennings. "It's also for anyone who is a caregiver to someone at risk of or already beginning to suffer from dementia. It offers a hopeful, healthy way forward.”

Jennings, who maintains a private practice in Chattanooga, TN, has authored several books, including The God-Shaped Brain and The God-Shaped Heart. He is a Distinguished Fellow of the American Psychiatric Association and Fellow of the Southern Psychiatric Association, and is president and founder of Come and Reason Ministries.

For more information about Dr. Jennings, please visit the website: https://www.agingbrainbook.com.

To connect with Dr. Jennings, please visit: https://www.facebook.com/DrTimJennings/ and https://twitter.com/timjenningsmd.

The Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind
Baker Books
Released: June 2018
ISBN-10: 080107522X
ISBN-13: 978-0801075223

###

Reviews for The Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind:

Dr. Caroline Leaf, Cognitive Neuroscientist, Communication Pathologist and Author: "Great advice and excellent science on aging! It's well worth following and applying these principles so as to age the way we are supposed to.”

Rodney A. Poling, MD, DFAPA, medical director, Behavioral Healthcare Center, Columbia TN., and board-certified geriatric psychiatrist: "A well-researched and commonsense book aimed at helping one understand the complexities of dementia, while offering recommendations for maintaining healthy brain function into our later years.”

Michael Lyles, psychiatrist, author, and speaker: "Dr. Jennings clearly describes how to practically manage the medical and lifestyle variables that can positively impact brain health and the process of aging. Age is a number, but getting old is a lifestyle.”

The Future of Fitness is Here: Peloton Launches in Canada

 

New, game changing category of exercise offers live and on-demand boutique studio classes in the home environment

TORONTO, Oct. 11, 2018 /CNW/ - The future of fitness is about to cycle its way into homes across Canada. According to a new survey by Ipsos conducted in October about the exercise habits of Canadians, it should be welcome news: three quarters of Canadians aged 25 to 64 say making time to get to an exercise class is difficult and that it's more convenient for them to exercise on their own schedule. The launch of US fitness sensation Peloton this week offers Canadians an entirely new way to work out, without ever leaving their homes.

If the Peloton brand sounds familiar, it should: since the launch of its at-home connected bike in 2014, the leading global technology company has become the go-to exercise regimen for everyone from high profile celebrities and CEOs to busy parents who need a more convenient way to exercise.

Dubbed by US media as 'the Netflix of fitness,' Peloton has created an entirely new category of fitness by bringing live and on-demand boutique studio classes to the convenience and comfort of the home environment. All content is produced in the brand's state-of-the-art NYC studio, run by award-winning television producers with world-class instructors leading the pack. Viewed as an industry disruptor, the company uses technology and design to connect the world through fitness, empowering people to be the best version of themselves anywhere, anytime, while allowing their community to feel the rush and competitive nature of a studio.

The company, which has more than doubled its size each year since inception, was founded by entrepreneur John Foley.  Foley, and his wife Jill -- boutique fitness studio enthusiasts -- found it difficult to attend classes after becoming new, time-strapped parents.  Peloton was the solution they imagined filling an immediate need for busy individuals.  To date, the company has raised almost $1 billion in financing and is valued at $4 billion.  Peloton enters Canada following its UK launch in late September, which marked the company's first foray outside the US market.

To kick off the much-anticipated Canadian launch, the brand is opening a retail showroom in Toronto for guests to try the category-creating Bikes, Peloton Toronto, located at 130 Bloor Street West, will open October 12th, and will offer the ultimate cycling experience, where guests will get to test ride the Bike, get a personalized tutorial and learn more about the Peloton experience.  Beyond the Bloor Street showroom, the company will also open a Yorkdale Shopping Centre location (Toronto) later in October and two stores in Western Canada in November (West Edmonton Mall, Edmonton, CF Chinook Centre, Calgary). Bikes will also be available to purchase directly online at www.onepeloton.ca. The Canadian expansion plans to see another 10 showrooms open in the next 12-18 months.

"Technology has changed everything, from the way we watch television to the way we travel – fitness is the next industry going through a revolution and Peloton is excited to be at the forefront of this movement," said Kevin Cornils, International Managing Director, Peloton. "Clearly, Canadians want to work out -- but the reality is that 80 percent want to work out on their own time, when they're available, not on someone else's schedule. Our mission at Peloton is to change the fitness game by bringing the energy of studio-style, group fitness classes to homes around the world, one Bike at a time."

Using its revolutionary indoor Bike, Peloton streams 14 daily live – and 10,000+ on-demand – immersive cycling classes, so users can enjoy the intensity and excitement of classes taught by the world's best instructors without leaving the house.  The Peloton Bike retails in Canada for $2,950 (including Delivery & Setup) plus $49 per month for access to Peloton Digital's unlimited class subscription, which includes cycling, as well as "Floor" workouts such as running, bootcamp, strength, stretching and yoga.

Interview Availability:

Managing Director Kevin Cornils is in Toronto and available for interviews Thursday October 11th and Friday October 12th.  Please contact Rob Loschiavo to arrange an interview rob@pomppr.com or 647-229-8412. 

Survey Highlights

  • 75% of Canadians agree that making time to get to an exercise class is difficult, led by 81% of Ontarians
  • 77% say it's more convenient for them to exercise at home than go the gym
  • 70% say they'd work out more if they could do it from the convenience of their own home
  • 84% want to work out on their own time, when they're available, not on a schedule, this number rises to 89% among 35-54 year olds
  • 40% of Canadians get less than 30 minutes of activity per day
  • Most Canadians (73%) prefer to engage in physical activity on their own vs. 27% who prefer doing so with other people
  • One in six (17%) incorporate spinning (indoor cycling) into their exercise or physical activity
  • Time (40%), laziness (29%), scheduling (25%), are the top three barriers Canadians report to getting exercise. In particular, men are more likely to cite not enough time (45%) and not fitting with their schedule (30%) as barriers. 42% of those under 35 say they're too lazy
  • 64% say working out with others motivates them to work harder, led by BC residents (68%)
  • 62% say they get bored easily when working out, including 70% of those aged 25-34 and 67% of Ontarians

 

The survey was conducted by Ipsos in October 2018, among a sample of 1,000 Canadians aged 25-64 with a household income of at least $60,000. The results are considered accurate to within +/- 3.5 percentage points, 19 times out of 20.

How to book a trial of the Peloton Bike at Peloton Toronto:
Sign up to book your ride at toronto.onepeloton.com

About Peloton
Founded in 2012, Peloton is reinventing fitness by bringing live and on-demand boutique-style studio classes to the convenience and comfort of your own home. Our immersive fitness content, taught by Peloton's roster of elite instructors, features real-time motivation and curated playlists of your favorite artists. The Peloton experience can be accessed through the Peloton Bike, the Peloton Tread, or Peloton Digital, an iOS app that offers an all-access pass to a full slate of fitness offerings, anytime, anywhere. Peloton is changing the way people get fit through a comprehensive and socially connected experience that makes every workout both efficient and addictive. The company has a growing number of retail showrooms across the US and, starting this fall, in Canada and the UK. For more information, visit www.onepeloton.ca.

SOURCE Peloton

Premier Health Group Inc.'s HealthVue Selects Reliq Health Technologies as Exclusive Technology Partner for Development of Telemedicine App for its 100,000+ Patients

 

VANCOUVER, Oct. 11, 2018 /CNW/ - Premier Health Group (CSE: PHGI) (OTCQB: PHGRF) (the "Company" or "Premier Health"), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce that it has selected Reliq Health Technologies Inc. ("Reliq") (TSXV: RHT) (OTCQB: RQHTF) as its exclusive technology partner. Reliq will be providing Premier's subsidiary, HealthVue, primary care clinics with a HealthVue-branded telemedicine, remote monitoring & AI solution for its clinical staff and more than 100,000 active patients.

"We are very excited to be selected by Premier Health Group as the exclusive technology partner for their HealthVue Clinics. We look forward to helping HealthVue establish themselves as a technology leader in primary care," said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Incorporating Reliq's technology platform into their clinics will allow HealthVue to improve access to care and convenience for patients, supporting HealthVue's goal of rapidly increasing their patient numbers and practice revenues. Reliq and HealthVue will share in new practice revenue streams created by the implementation of this technology platform. Expanding our user base into British Columbia with this partnership and into Australia with our recently announced pilots there clearly validates the relevance of our solution in multiple different clinical applications, geographies and healthcare systems."

"The HealthVue patient app powered by Reliq Health's technology platform will allow patients to book appointments, see their GP or a specialist via telemedicine, review their own chart, chat with clinic staff and pharmacists, refill prescriptions and share health data collected in the home with their HealthVue care team," said Dr. Essam Hamza, MD, CEO of HealthVue. "Telemedicine visits are already covered by the provincial health insurance plans in several provinces so there is no cost to the patient to access this service, which we will ultimately be able to offer to patients 24/7. The technology component of our practice is easily scalable, low cost and high margin, allowing us to rapidly grow our business and create significant shareholder value."

HealthVue expects to make the first version of the app available to their patients in Q4-18.

ON BEHALF OF THE BOARD OF DIRECTORS
"Dr. Essam Hamza, MD"
Chief Executive Officer

About Premier Health

Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are developing innovative health care approaches that combine human skill based expertise with emerging technologies, and will set the gold standard for services in locations of interest worldwide. Premier Health's subsidiary, HealthVue is focused on developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence (AI). We currently have an ecosystem of over 100,000 active patients and have plans to rapidly increase that number both domestically and internationally. The HealthVue team has a strong track record of successfully creating value in healthcare and technology enterprises. The Management team has deep clinical, financial and operational expertise and a passion for improving healthcare for all patients.

About Reliq Health Technologies

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq's powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

Cautionary Statements

This news release contains forward-looking statements that are based on Premier Health's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Premier Health believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Premier Health undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

SOURCE Premier Health Group Inc.